The neuroimaging and clinical spectrum of neurofibromatosis 2

Author(s): Lindenau, M., Baser, M. E., Hazim, W., Tatagiba, M., Haase, W., Samii, M., Wais, R., Pulst, S. M.

Journal/Book: Neurosurgery. 1996; 38: 351 West Camden St, Baltimore, MD 21201-2436. Williams & Wilkins. 880-885.

Abstract: NEUROFIBROMATOSIS 2 (NF2) is an autosomal dominant disease predisposing to multiple tumors of the central and peripheral nervous system. Bilateral vestibular schwannomas are the hallmark of the disease. To define the clinical spectrum of the disease, we performed gadolinium-enhanced magnetic resonance imaging of the brain and spine as well as neurological, dermatological, and ocular examinations in 48 patients with NF2 diagnosed with the National Institutes of Health diagnostic criteria. Patients were ascertained from patient workshops and publications and from referral as a result of vestibular schwannoma surgery. Vestibular schwannomas were found in 46 patients (96%, 43 bilateral and 3 unilateral), spinal tumors were found in 43 (90%), posterior subcapsular cataracts were found in 30 (63%), meningiomas were found in 28 (58%), and trigeminal schwannomas were found in 14 (29%). The presenting symptoms included hearing loss or tinnitus in 15 patients (31%), multiple or nonspecific symptoms in 15 (31%), skin tumors in 12 (25%), and ocular symptoms in 6 (13%). When the complete spine was imaged, spinal tumors were more common in patients with NF2 than has previously been reported. This is a noteworthy finding, because spinal tumors are a major cause of NF2 morbidity and mortality.

Note: Article ME Baser, Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Div Neurol, Room 8907 S Tower, Los Angeles, CA 90048 USA

Keyword(s): brain tumors; mutation analysis; neurofibromatosis 2; ocular spectrum; phenotype classification; spinal tumors; vestibular schwannoma; BILATERAL ACOUSTIC NEUROFIBROMATOSIS; TYPE-2; HAMARTOMAS; FUNDUS

Zurück | Weiter